These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28012798)

  • 1. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
    Donato MT; Tolosa L
    Differentiation; 2019; 106():15-22. PubMed ID: 30844688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of a Method of Hepatocyte Differentiation from Human Pluripotent Stem Cells for Innovative Drug Development].
    Takayama K
    Yakugaku Zasshi; 2015; 135(10):1141-6. PubMed ID: 26423870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
    Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
    Mitani S
    Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient derivation of functional hepatocytes from mouse induced pluripotent stem cells by a combination of cytokines and sodium butyrate.
    Zhang Q; Yang Y; Zhang J; Wang GY; Liu W; Qiu DB; Hei ZQ; Ying QL; Chen GH
    Chin Med J (Engl); 2011 Nov; 124(22):3786-93. PubMed ID: 22340242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing.
    Takayama K; Kawabata K; Nagamoto Y; Kishimoto K; Tashiro K; Sakurai F; Tachibana M; Kanda K; Hayakawa T; Furue MK; Mizuguchi H
    Biomaterials; 2013 Feb; 34(7):1781-9. PubMed ID: 23228427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.
    Song Z; Cai J; Liu Y; Zhao D; Yong J; Duo S; Song X; Guo Y; Zhao Y; Qin H; Yin X; Wu C; Che J; Lu S; Ding M; Deng H
    Cell Res; 2009 Nov; 19(11):1233-42. PubMed ID: 19736565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.
    Javed MS; Yaqoob N; Iwamuro M; Kobayashi N; Fujiwara T
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):91-6. PubMed ID: 24491001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture.
    Vosough M; Omidinia E; Kadivar M; Shokrgozar MA; Pournasr B; Aghdami N; Baharvand H
    Stem Cells Dev; 2013 Oct; 22(20):2693-705. PubMed ID: 23731381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.
    Takayama K; Morisaki Y; Kuno S; Nagamoto Y; Harada K; Furukawa N; Ohtaka M; Nishimura K; Imagawa K; Sakurai F; Tachibana M; Sumazaki R; Noguchi E; Nakanishi M; Hirata K; Kawabata K; Mizuguchi H
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):16772-7. PubMed ID: 25385620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
    Greenhough S; Medine CN; Hay DC
    Toxicology; 2010 Dec; 278(3):250-5. PubMed ID: 20674645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPα, and PROX1 transduction.
    Nakamori D; Takayama K; Nagamoto Y; Mitani S; Sakurai F; Tachibana M; Mizuguchi H
    Biochem Biophys Res Commun; 2016 Jan; 469(3):424-9. PubMed ID: 26679606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of hepatocytes from pluripotent stem cells.
    Mallanna SK; Duncan SA
    Curr Protoc Stem Cell Biol; 2013 Sep; 26():1G.4.1-1G.4.13. PubMed ID: 24510789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of a Novel Hepatocyte Model Using Stem Cells for Pharmaceutical Research].
    Toba-Ueyama Y
    Yakugaku Zasshi; 2023; 143(11):905-909. PubMed ID: 37914337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaceutical Research on Liver Diseases Using iPS Cell and Genome Editing Technologies].
    Takayama K
    Yakugaku Zasshi; 2019; 139(10):1219-1225. PubMed ID: 31582604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.